Literature DB >> 15085560

Naltrexone antagonism of morphine antinociception in sucrose- and chow-fed rats.

Kristen E D'Anci1, Robin B Kanarek.   

Abstract

Rats given long-term access to a palatable sucrose solution are more sensitive to (1) the analgesic potency of morphine and (2) the anorectic actions of naltrexone. In the present experiment, the ability of naltrexone to antagonize the antinociceptive properties of morphine was examined in sucrose- and chow-fed rats. Twenty adult male Long-Evans rats were maintained on chow and water. Ten rats were also given ad libitum access to a 32% sucrose solution for three weeks. Baseline and post-drug nociceptive thresholds were determined with a warm water (52 degrees C) tail-withdrawal procedure. Complete morphine dose-effect curves (0.32-100.0 mg/kg) were determined alone and in the presence of naltrexone (0.32-0.32 mg/kg). Morphine produced significant increases in tail-withdrawal latencies in both groups of animals. Rats drinking sucrose had significantly longer tail-withdrawal latencies than rats given only chow and water. Naltrexone produced significant and surmountable dose-dependent rightward shifts in the morphine dose-response curves for both groups, but did not differ in potency across diets. The present data support and extend our earlier findings showing sucrose enhancement of morphine-induced antinociception in rats given a palatable sucrose solution to drink.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15085560     DOI: 10.1080/1028415042000198807

Source DB:  PubMed          Journal:  Nutr Neurosci        ISSN: 1028-415X            Impact factor:   4.994


  2 in total

1.  Eating is a protected behavior even in the face of persistent pain in male rats.

Authors:  H Foo; Katherine Crabtree; Ama Thrasher; Peggy Mason
Journal:  Physiol Behav       Date:  2009-03-24

2.  Naloxone attenuates incubated sucrose craving in rats.

Authors:  Jeffrey W Grimm; Meghan Manaois; Dan Osincup; Barbara Wells; Carl Buse
Journal:  Psychopharmacology (Berl)       Date:  2007-07-13       Impact factor: 4.530

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.